LoginSignup
BB Biotech logo

BB Biotech

Stock
Stock
ISIN: CH0038389992
Ticker: BION
CH0038389992
BION

Price

Price

Historical dividends and forecast

All dividend data

BB Biotech has so far distributed $2.209 in 2024. The next dividend will be paid on 27.03.2025

$2.789

CHART BY

Frequently asked questions

What is BB Biotech's market capitalization?

The market capitalization of BB Biotech is $2.25B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is BB Biotech's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for BB Biotech is 15.84. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for BB Biotech?

BB Biotech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.558. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for BB Biotech's stock?

Currently, 5 analysts cover BB Biotech's stock, with a consensus target price of $63.17. Analyst ratings provide insights into the stock's expected performance.

What is BB Biotech's revenue over the trailing twelve months?

Over the trailing twelve months, BB Biotech reported a revenue of $305.10M.

What is the EBITDA for BB Biotech?

BB Biotech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $262.55M. EBITDA measures the company's overall financial performance.

What is the free cash flow of BB Biotech?

BB Biotech has a free cash flow of $41.12M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of BB Biotech's stock?

The 5-year beta for BB Biotech is 1.10. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

What is the free float of BB Biotech's shares?

The free float of BB Biotech is 53.85M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.25B

5Y beta

 1.10

EPS (TTM)

 $2.558

Free Float

 53.85M

P/E ratio (TTM)

 15.84

Revenue (TTM)

 $305.10M

EBITDA (TTM)

 $262.55M

Free Cashflow (TTM)

 $41.12M

Pricing

1D span
$40.63$40.68
52W span
$40.33$56.73

Analyst Ratings

The price target is $63.17 and the stock is covered by 5 analysts.

Buy

5

Hold

0

Sell

0

Information

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.

Biotechnology & Drugs

Health Care

Identifier

ISIN

CH0038389992

Primary Ticker

BION

Knockouts

Join the conversation
Sign upLogin